Noah Berkowitz insider trades: Arvinas (ARVN) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Noah reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 11, 2026 | ARVN | ↓ Sell | 11,108 | $9.94 | $110K | Direct | May 13, 2026 (2d) |
| Feb 13, 2026 | ARVN | ↓ Sell | 5,685 | $11.89 | $68K | Direct | Feb 18, 2026 (5d) |
| Mar 18, 2025 | ARVN | ↓ Sell | 8,658 | $8.59 | $74K | Direct | Mar 19, 2025 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ARVN insiders
Open-market trades in the last 12 months
About Noah Berkowitz's insider trades
Noah Berkowitz is Chief Medical Officer at Arvinas (ARVN). Since Mar 18, 2025, Noah has reported no open-market purchases and 3 sales worth $252K on SEC Form 4. In the last 12 months: 2 sales ($178K).
Their filings also include grants and awards (8 filings), shares returned to the company (8 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ARVN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.